WO2025210520 - LIPID NANOPARTICLES FOR INDUCING AN IMMUNOLOGICAL RESPONSE
National phase entry is expected:
Publication Number
WO/2025/210520
Publication Date
09.10.2025
International Application No.
PCT/IB2025/053435
International Filing Date
02.04.2025
Title **
[English]
LIPID NANOPARTICLES FOR INDUCING AN IMMUNOLOGICAL RESPONSE
[French]
NANOPARTICULES LIPIDIQUES POUR INDUIRE UNE RÉPONSE IMMUNOLOGIQUE
Applicants **
GENEVANT SCIENCES GMBH
Inventors
SCHREINER, Petra
DALY, Owen
LAM, Kieu
HEYES, James
Priority Data
63/574,476
04.04.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 4031 | |
| EPO | Filing, Examination, Granting | 54307 | |
| Japan | Filing, Examination, Granting | 3910 | |
| South Korea | Filing, Examination, Granting | 5507 | |
| USA | Filing, Examination, Granting | 16740 |
Total:
84,495
Contact Us
Abstract[English]
The present disclosure provides lipid nanoparticles that are particularly beneficial in inducing an immune response in a subject, particularly by stimulating production of antibodies by the subject. The lipid nanoparticles can include one or more of a low conjugated lipid concentration, a neutral phospholipid, and a concentration of an ionizable lipid and/or sterol that satisfy certain thresholds dependent on the conjugated lipid concentration. The disclosure also provides vaccines, other pharmaceutical compositions, and methods including the provided lipid nanoparticles.[French]
La présente divulgation propose des nanoparticules lipidiques qui sont particulièrement bénéfiques pour induire une réponse immunitaire chez un sujet, en particulier par stimulation de la production d'anticorps par le sujet. Les nanoparticules lipidiques peuvent comprendre un ou plusieurs éléments parmi une faible concentration en lipides conjugués, un phospholipide neutre et une concentration d'un lipide et/ou d'un stérol ionisable qui satisfont certains seuils en fonction de la concentration en lipides conjugués. La divulgation propose également des vaccins, d'autres compositions pharmaceutiques et des méthodes comprenant les nanoparticules lipidiques fournies.